Changes in Immune Cell Profile, Clinical and Safety Outcomes in Fingolimod-Treated Patients With Relapsing Multiple Sclerosis in the FLUENT Study

被引：0
|
作者：
Mao-Draayer, Y. [1 ]
Cohen, J. A. [2 ]
Bar-Or, A. [3 ]
Han, M. H. [4 ]
Singer, B. [5 ]
Jaitly, N. [6 ]
Kolodny, S. [6 ]
Elam, C. [6 ]
Meng, X. [6 ]
Ziehn, M. [6 ]
Cree, B. A. [7 ]
机构：
[1] Univ Michigan, Ann Arbor, MI USA
[2] Cleveland Clin, Cleveland, OH USA
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Stanford Univ, Stanford, CA USA
[5] Missouri Baptist Med Ctr, St Louis, MO USA
[6] Novartis Pharmaceut, E Hanover, NJ USA
[7] UCSF, San Francisco, CA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P053
引用
收藏
页码：40 / 41
页数：2
相关论文
共 50 条
  • [1] Changes in immune cell profile, clinical and safety outcomes in fingolimod-treated patients with relapsing multiple sclerosis in the FLUENT study
    Mao-Draayer, Yang
    Cohen, Jeffrey A.
    Bar-Or, Amit
    Han, May H.
    Singer, Barry
    Jaitly, Nina
    Kolodny, Scott
    Elam, Chelsea
    Meng, Xiangyi
    Ziehn, Marina
    Cree, Bruce A. C.
    [J]. NEUROLOGY, 2020, 94 (15)
  • [2] Changes in the immune cell profile in fingolimod-treated patients with relapsing multiple sclerosis: primary analysis of the FLUENT study
    Mao-Draayer, Yang
    Cohen, Jeffrey
    Bar-Or, Amit
    Cree, Bruce A. C.
    Han, May
    Singer, Barry
    Kolodny, Scott
    Meng, Xiangyi
    Schofield, Lesley
    Ziehn, Marina
    [J]. NEUROLOGY, 2019, 92 (15)
  • [3] Immune cell profiles and clinical and safety outcomes with fingolimod in the 12 month fluent study of patients with relapsing multiple sclerosis
    Mao-Draayer, Y.
    Cohen, J.
    Bar-Or, A.
    Han, M.
    Singer, B.
    Kolodny, S.
    Elam, C.
    Meng, X.
    Ziehn, M.
    Cree, B.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 221 - 221
  • [4] The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod
    Cohen, Jeffrey A.
    Bar-Or, Amit
    Cree, Bruce A. C.
    Mao-Draayer, Yang
    Han, May H.
    Singer, Barry
    Jannu, Ann
    Kolodny, Scott
    Meng, Xiangyi
    Winger, Ryan C.
    [J]. MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2019, 5 (01)
  • [5] Immune Cell Subset and Biomarker Changes in Patients with Relapsing Multiple Sclerosis Receiving Fingolimod: Interim Analysis of the FLUENT Study
    Mao-Draayer, Yang
    Cohen, Jeffrey A.
    Bar-Or, Amit
    Cree, Bruce A. C.
    Han, May H.
    Singer, Barry A.
    Kolodny, Scott
    Meng, Xiangyi
    Schofield, Lesley
    Ziehn, Marina O.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 25 - 25
  • [6] Antigen-Specific Adaptive Immune Responses in Fingolimod-Treated Multiple Sclerosis Patients
    Mehling, Matthias
    Hilbert, Patricia
    Fritz, Stefanie
    Durovic, Bojana
    Eichin, Dominik
    Gasser, Olivier
    Kuhle, Jens
    Klimkait, Thomas
    Lindberg, Raija L. P.
    Kappos, Ludwig
    Hess, Christoph
    [J]. ANNALS OF NEUROLOGY, 2011, 69 (02) : 408 - 413
  • [7] Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis
    Kappos, Ludwig
    Mehling, Matthias
    Arroyo, Rafael
    Izquierdo, Guillermo
    Selmaj, Krzysztof
    Curovic-Perisic, Valentina
    Keil, Astrid
    Bijarnia, Mahendra
    Singh, Arun
    von Rosenstiel, Philipp
    [J]. NEUROLOGY, 2015, 84 (09) : 872 - 879
  • [8] Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis
    Henault, David
    Galleguillos, Lorna
    Moore, Craig
    Johnson, Trina
    Bar-Or, Amit
    Antel, Jack
    [J]. NEUROLOGY, 2013, 81 (20) : 1768 - 1772
  • [9] Clinical and MRI outcomes in fingolimod-treated relapsing remitting multiple sclerosis (RRMS) patients previously exposed to natalizumab: an 18-month follow-up
    Rinaldi, F.
    Miante, S.
    Perini, P.
    Seppi, D.
    Atzori, M.
    Gallo, P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 249 - 249
  • [10] Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient
    Lysandropoulos, Andreas P.
    Benghiat, Fleur
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 1551 - 1552
12345